Specific examples of these conditions include mutations in the SLC2A1 gene, which encodes the glucose transporter GLUT1, as well as metabolic disorders such as mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and myoclonic epilepsy with ragged red fibers (MERRF) syndromes. This evidence concerns the gene SLC2A1 and metabolic disease.